A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Various Degrees of Hepatic Impairment
Clinical trial NCT05481411 · COMPLETED
Trial details
- NCT number
- NCT05481411
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2023-04-05
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.